three current news stories from around the world:
Stock Titan Yahoo Finance CBS News Here are three current news stories from around the world: 1. Inovio Pharmaceuticals, Inc. completes rolling BLA submission for its DNA immunotherapy ( Stock Titan ) Biotech firm Inovio (ticker: INO) announced that it has completed the rolling submission of a Biologics License Application (BLA) for its investigational DNA-immunotherapy candidate INO‑3107, designed to treat adult patients with recurrent respiratory papillomatosis (RRP). The submission was made under the U.S. Food & Drug Administration’s Accelerated Approval programme, and the company has asked for priority review. Key points: INO-3107 already has Orphan Drug and Breakthrough Therapy designations. ( Stock Titan ) Inovio expects FDA file acceptance by end of 2025 and a possible PDUFA (decision) date in mid-2026 if priority review is granted. ( Stock Titan ) If approved, INO-3107 would be Inovio’s first commercial product and the first DNA medicine marketed ...